164 related articles for article (PubMed ID: 27553833)
1. Exportin-5 Functions as an Oncogene and a Potential Therapeutic Target in Colorectal Cancer.
Shigeyasu K; Okugawa Y; Toden S; Boland CR; Goel A
Clin Cancer Res; 2017 Mar; 23(5):1312-1322. PubMed ID: 27553833
[No Abstract] [Full Text] [Related]
2. Overexpression of Exportin-5 Overrides the Inhibitory Effect of miRNAs Regulation Control and Stabilize Proteins via Posttranslation Modifications in Prostate Cancer.
Höti N; Yang S; Aiyetan P; Kumar B; Hu Y; Clark D; Eroglu AU; Shah P; Johnson T; Chowdery WH; Zhang H; Rodriguez R
Neoplasia; 2017 Oct; 19(10):817-829. PubMed ID: 28881308
[TBL] [Abstract][Full Text] [Related]
3. Effects of Knockdown of XPO5 by siRNA on the Biological Behavior of Head and Neck Cancer Cells.
Özdaş S; Canatar İ; Özdaş T
Laryngoscope; 2022 Mar; 132(3):569-577. PubMed ID: 34328643
[TBL] [Abstract][Full Text] [Related]
4. Induction of exportin-5 expression during melanoma development supports the cellular behavior of human malignant melanoma cells.
Ott CA; Linck L; Kremmer E; Meister G; Bosserhoff AK
Oncotarget; 2016 Sep; 7(38):62292-62304. PubMed ID: 27556702
[TBL] [Abstract][Full Text] [Related]
5. A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells.
Melo SA; Moutinho C; Ropero S; Calin GA; Rossi S; Spizzo R; Fernandez AF; Davalos V; Villanueva A; Montoya G; Yamamoto H; Schwartz S; Esteller M
Cancer Cell; 2010 Oct; 18(4):303-15. PubMed ID: 20951941
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the Oncogenic and Tumor Suppressor Role of XPO5 in Different Tissue Tumor Types.
Khan M; Khan Z; Uddin Y; Mustafa S; Shaukat I; Pan J; Höti N
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1119-1125. PubMed ID: 29699373
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-217 functions as a prognosis predictor and inhibits colorectal cancer cell proliferation and invasion via an AEG-1 dependent mechanism.
Wang B; Shen ZL; Jiang KW; Zhao G; Wang CY; Yan YC; Yang Y; Zhang JZ; Shen C; Gao ZD; Ye YJ; Wang S
BMC Cancer; 2015 May; 15():437. PubMed ID: 26016795
[TBL] [Abstract][Full Text] [Related]
8. Nuclear export mediated regulation of microRNAs: potential target for drug intervention.
Muqbil I; Bao B; Abou-Samra AB; Mohammad RM; Azmi AS
Curr Drug Targets; 2013 Sep; 14(10):1094-100. PubMed ID: 23834155
[TBL] [Abstract][Full Text] [Related]
9. An Exportin-1-dependent microRNA biogenesis pathway during human cell quiescence.
Martinez I; Hayes KE; Barr JA; Harold AD; Xie M; Bukhari SIA; Vasudevan S; Steitz JA; DiMaio D
Proc Natl Acad Sci U S A; 2017 Jun; 114(25):E4961-E4970. PubMed ID: 28584122
[TBL] [Abstract][Full Text] [Related]
10. XPO5 genetic polymorphisms in cancer risk and prognosis.
Patrão AS; Dias F; Teixeira AL; Maurício J; Medeiros R
Pharmacogenomics; 2018 Jun; 19(9):799-808. PubMed ID: 29790454
[TBL] [Abstract][Full Text] [Related]
11. The Role of Exportin-5 in MicroRNA Biogenesis and Cancer.
Wu K; He J; Pu W; Peng Y
Genomics Proteomics Bioinformatics; 2018 Apr; 16(2):120-126. PubMed ID: 29723684
[TBL] [Abstract][Full Text] [Related]
12. miR-204-5p inhibits proliferation and invasion and enhances chemotherapeutic sensitivity of colorectal cancer cells by downregulating RAB22A.
Yin Y; Zhang B; Wang W; Fei B; Quan C; Zhang J; Song M; Bian Z; Wang Q; Ni S; Hu Y; Mao Y; Zhou L; Wang Y; Yu J; Du X; Hua D; Huang Z
Clin Cancer Res; 2014 Dec; 20(23):6187-99. PubMed ID: 25294901
[TBL] [Abstract][Full Text] [Related]
13. Re-evaluation of the roles of DROSHA, Export in 5, and DICER in microRNA biogenesis.
Kim YK; Kim B; Kim VN
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1881-9. PubMed ID: 26976605
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA ciRS-7-A Promising Prognostic Biomarker and a Potential Therapeutic Target in Colorectal Cancer.
Weng W; Wei Q; Toden S; Yoshida K; Nagasaka T; Fujiwara T; Cai S; Qin H; Ma Y; Goel A
Clin Cancer Res; 2017 Jul; 23(14):3918-3928. PubMed ID: 28174233
[No Abstract] [Full Text] [Related]
15. A precursor microRNA in a cancer cell nucleus: get me out of here!
Melo SA; Esteller M
Cell Cycle; 2011 Mar; 10(6):922-5. PubMed ID: 21346411
[TBL] [Abstract][Full Text] [Related]
16. Downregulation and tumor-suppressive role of XPO5 in hepatocellular carcinoma.
Li Y; Wang X; He B; Cai H; Gao Y
Mol Cell Biochem; 2016 Apr; 415(1-2):197-205. PubMed ID: 27000860
[TBL] [Abstract][Full Text] [Related]
17. FOXM1 and FOXQ1 Are Promising Prognostic Biomarkers and Novel Targets of Tumor-Suppressive miR-342 in Human Colorectal Cancer.
Weng W; Okugawa Y; Toden S; Toiyama Y; Kusunoki M; Goel A
Clin Cancer Res; 2016 Oct; 22(19):4947-4957. PubMed ID: 27162244
[TBL] [Abstract][Full Text] [Related]
18. miR-133a acts as a tumor suppressor in colorectal cancer by targeting eIF4A1.
Li W; Chen A; Xiong L; Chen T; Tao F; Lu Y; He Q; Zhao L; Ou R; Xu Y
Tumour Biol; 2017 May; 39(5):1010428317698389. PubMed ID: 28466778
[TBL] [Abstract][Full Text] [Related]
19. Association of microRNA-related gene XPO5 rs11077 polymorphism with susceptibility to thyroid cancer.
Wen J; Gao Q; Wang N; Zhang W; Cao K; Zhang Q; Chen S; Shi L
Medicine (Baltimore); 2017 Apr; 96(14):e6351. PubMed ID: 28383405
[TBL] [Abstract][Full Text] [Related]
20. ADNP Is a Therapeutically Inducible Repressor of WNT Signaling in Colorectal Cancer.
Blaj C; Bringmann A; Schmidt EM; Urbischek M; Lamprecht S; Fröhlich T; Arnold GJ; Krebs S; Blum H; Hermeking H; Jung A; Kirchner T; Horst D
Clin Cancer Res; 2017 Jun; 23(11):2769-2780. PubMed ID: 27903678
[No Abstract] [Full Text] [Related]
[Next] [New Search]
